Login
Companies $CRVS
$10.81 +$0.21 (1.98%) After hours
Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc.

corvuspharma.com

What Do They Do?

Develops drug candidates that target immune-cell proteins for people with cancers and immune-mediated and inflammatory diseases.

How Do They Make Money?

No revenue reported yet.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −100% (Loss)
vs −$10.2M in Q3 FY2025

Who Do They Compete With?

Competes with Abbvie, Pfizer, Sanofi, Amgen, GSK, Lilly, Arcus Biosciences, and AstraZeneca

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support